IRIS
BONINI, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.316
NA - Nord America 4.333
EU - Europa 3.499
SA - Sud America 2.722
AF - Africa 177
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.067
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.104
SG - Singapore 3.602
BR - Brasile 2.248
CN - Cina 2.065
HK - Hong Kong 1.163
SE - Svezia 1.136
IT - Italia 880
VN - Vietnam 788
RU - Federazione Russa 412
DE - Germania 319
AR - Argentina 191
GB - Regno Unito 142
FI - Finlandia 133
IN - India 129
EC - Ecuador 103
JP - Giappone 101
CA - Canada 97
AT - Austria 92
BD - Bangladesh 90
MX - Messico 81
ID - Indonesia 79
NL - Olanda 71
ZA - Sudafrica 64
FR - Francia 60
IE - Irlanda 59
CO - Colombia 57
PY - Paraguay 48
TR - Turchia 47
PL - Polonia 46
ES - Italia 41
IQ - Iraq 41
MA - Marocco 30
PK - Pakistan 30
UZ - Uzbekistan 28
SA - Arabia Saudita 25
UA - Ucraina 22
VE - Venezuela 22
EG - Egitto 19
CL - Cile 18
DZ - Algeria 18
TN - Tunisia 18
CH - Svizzera 17
IL - Israele 16
UY - Uruguay 16
PE - Perù 14
KE - Kenya 13
AU - Australia 12
IR - Iran 12
DO - Repubblica Dominicana 11
LT - Lituania 11
KR - Corea 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
JM - Giamaica 8
BB - Barbados 7
TH - Thailandia 7
TW - Taiwan 7
AM - Armenia 6
KW - Kuwait 6
NP - Nepal 6
NZ - Nuova Zelanda 6
AL - Albania 5
DK - Danimarca 5
GE - Georgia 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
PT - Portogallo 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
KG - Kirghizistan 4
MY - Malesia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DM - Dominica 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
SC - Seychelles 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
KH - Cambogia 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
Totale 19.048
Salva come PNG Salva come JPEG
Città #
Singapore 1.412
Hong Kong 1.091
Dallas 777
Ashburn 545
Shanghai 531
Hefei 461
Lawrence 409
Princeton 409
Ho Chi Minh City 311
Milan 309
Beijing 272
New York 233
São Paulo 178
Hanoi 151
Moscow 145
Los Angeles 119
Nuremberg 97
Helsinki 83
Boardman 81
Rio de Janeiro 79
Tokyo 61
Rome 60
Munich 58
Dublin 55
Belo Horizonte 46
Vienna 46
Brasília 44
Denver 41
Guangzhou 40
Montreal 38
Warsaw 38
Guayaquil 37
Brooklyn 36
Da Nang 36
Johannesburg 36
Washington 36
Quito 35
Turku 34
Orem 33
Stockholm 32
Haiphong 31
Poplar 31
Santa Clara 31
Boston 29
Brescia 29
Phoenix 29
Tashkent 27
Ankara 25
Campinas 25
Chennai 25
Curitiba 25
Mexico City 25
Atlanta 24
London 24
Porto Alegre 24
Salvador 23
Pune 22
Toronto 22
Amsterdam 21
Biên Hòa 20
Frankfurt am Main 20
Hangzhou 20
Houston 20
Manchester 20
Goiânia 19
The Dalles 19
Mumbai 18
Seattle 18
Shenzhen 18
Turin 18
Guarulhos 17
Manaus 17
Querétaro 17
Recife 17
Santo André 17
Tianjin 17
Caxias do Sul 16
Chicago 16
Dhaka 16
Fortaleza 16
Lappeenranta 16
Shijiazhuang 16
São Gonçalo 16
Thái Bình 16
Betim 15
Asunción 14
Bergamo 14
Buenos Aires 14
Council Bluffs 14
Jakarta 14
Joinville 14
Montes Claros 14
San Jose 14
Can Tho 13
Cesano Boscone 13
Hải Dương 13
Montevideo 13
Nairobi 13
Osasco 13
Bauru 12
Totale 9.684
Salva come PNG Salva come JPEG
Nome #
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 192
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 192
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 167
Loss of mismatched HLA in leukemia after stem-cell transplantation 135
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 132
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 124
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 123
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 118
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 115
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 113
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 106
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 106
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 100
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 96
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 95
A clinical protocol for gene transfer into peripheral blood lymphocytes for in vivo immunomodulation of donor anti-tumor immunity in patients affected by recurrent disease after allogeneic bone marrow transplantation 94
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 93
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 91
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 90
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 88
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety 87
A humanized Fas receptor-based suicide switch expressed in human T lymphocytes for the induction of controlled graft versus leukemia. 86
Biobanking for COVID-19 research 86
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 85
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 83
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 83
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 82
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 80
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 78
A dual role for genetically modified lymphocytes in cancer immunotherapy 77
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 76
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth 76
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 75
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 75
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 75
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 73
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 72
Adoptive T-cell therapy for cancer: The era of engineered T cells 71
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 70
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 70
Interleukin-7 improves the fitness of regulatory T cells for adoptive transfer 70
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 69
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 68
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 68
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR 67
819. Molecular Follow-Up of Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocytes Transduced with a Retroviral Vector Expressing HSV-TK and ∆LNGFR 67
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 67
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 67
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 67
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 66
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 66
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease 66
T cells for suicide gene therapy: Activation, functionality and clinical relevance 66
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 66
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 66
A model system for functional evaluation of isolated MHC disparities 65
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 65
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 65
Abrogation of GvHD and early immune reconstitution after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. 64
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 64
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 64
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 63
A pilot study of HSV-TK gene transfer into donor peripheral blood lymphocytes for controlled GVL after allo-BMT. 63
Combining Site-Specific Integration and Cassette Design to Achieve Robust Expression Without Impacting Endogenous Gene Expression 63
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 63
Erratum: Author Correction: Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer (Communications biology (2025) 8 1 DOI: 10.1038/s42003-024-07381-1.) 62
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 62
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 62
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 62
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 62
A strategy for introducing and targeting antigen in activated dendritic cells for simultaneous stimulation of CD4 and CD8 cells. 61
Enhancing anti-tumour efficacy with immunotherapy combinations 61
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 60
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 59
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study 59
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 58
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 58
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 58
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 57
Combining Targeted Integration and Cassette Design for Robust and Benign Transgene Expression without Impacting Endogenous Gene Transcription 57
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 57
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 57
Epigenetic checkpoints regulate the fate and function of CAR-T cells 56
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 56
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 56
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 55
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 55
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 54
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 54
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors 53
CMV-specific T Cell Counts Early after Allogeneic Hematopoietic Stem Cell Transplantation Stratify the Risk of Subsequent CMV Reactivations: Results of a Prospective Observational Study 53
FAS-based suicide gene strategy for controlled GvHD: An alternative to HSV-tk. 53
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 53
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 52
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 52
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 52
Suicide gene transduced for the regulation of the graft-versus-leukemia effect 51
Totale 7.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.427
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 7 70 0 5 0 0 0
2021/2022278 0 0 0 125 25 7 18 34 13 23 7 26
2022/20232.256 918 480 124 22 55 256 84 124 96 28 50 19
2023/20241.308 51 58 140 129 118 240 156 99 21 53 62 181
2024/20256.305 728 106 99 183 168 479 751 553 1.100 889 600 649
2025/20269.071 1.376 1.517 1.514 2.930 1.380 354 0 0 0 0 0 0
Totale 19.413